US Immunohistochemistry Market (2025-2030)
The US Immunohistochemistry Market was valued at $617.9 Million in 2025 and projected to reach to $899.7 Million by 2030, representing a compound annual growth rate of 7.8%. The US immunohistochemistry market is poised for sustained expansion through 2030, driven by rising cancer incidence rates, growing demand for biomarker identification, and the shift toward personalized medicine.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
US Immunohistochemistry Market Trends and Insights
- This growth trajectory underscores the US healthcare sector's increasing reliance on immunohistochemistry for cancer diagnosis, biomarker identification, and precision medicine applications.
- The US market benefits from advanced laboratory infrastructure, high healthcare spending, and strong adoption of diagnostic technologies across academic medical centers and commercial pathology laboratories. Driving expansion in the US immunohistochemistry market are rising cancer incidence rates, growing demand for personalized treatment approaches, and regulatory support for companion diagnostics.
- The US maintains a competitive advantage through innovation in antibody development, automated staining platforms, and digital pathology integration.
- Between 2025 and 2030, the US market will continue to consolidate around key players while emerging technologies reshape diagnostic workflows and expand clinical applications across oncology and immunology specialties..
Key Market Statistics
- CAGR (2025-2030) 7.8% CAGR
- Market Size, 2025 ~USD 617.9 Million
- Forecast, 2030 ~USD 899.7 Million
- Country US
US Immunohistochemistry Market Overview
Market Valuation Growth :
The US immunohistochemistry market is valued at $617.9 million in 2025 and is projected to reach $899.7 million by 2030, representing a robust 7.8% CAGR driven by increased adoption in diagnostic pathology.
Cancer Diagnosis Dominance :
US healthcare providers increasingly rely on immunohistochemistry for accurate cancer diagnosis and tumor classification, making it a cornerstone technology in oncology departments across major medical centers and regional hospitals.
Precision Medicine Integration :
The US market is experiencing accelerated growth due to the integration of immunohistochemistry with precision medicine initiatives, enabling personalized treatment strategies and improved patient outcomes in cancer care.
Advanced Healthcare Infrastructure :
The US benefits from cutting-edge laboratory infrastructure, high healthcare spending, and strong regulatory frameworks that support the adoption of advanced immunohistochemistry technologies and automated diagnostic solutions.
US Immunohistochemistry Market Dynamics
- Healthcare facilities are increasingly investing in advanced IHC platforms and automation technologies to improve diagnostic accuracy and operational efficiency.
- The market will benefit from continuous innovation in antibody development and digital pathology integration. Key growth catalysts include expanding reimbursement coverage, increased adoption of companion diagnostics, and the integration of artificial intelligence in pathology workflows.
- US pharmaceutical and biotechnology companies are driving demand through development of targeted therapies requiring IHC-based patient stratification.
- Regulatory support and clinical guideline updates will further accelerate market penetration across academic medical centers, community hospitals, and specialized diagnostic laboratories..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- The US immunohistochemistry market is valued at $617.9 million in 2025 and will reach $899.7 million by 2030, growing at 7.8% CAGR.
- Rising cancer prevalence and demand for precision medicine are primary growth drivers in the US market.
- The US benefits from advanced laboratory infrastructure and strong adoption of automated diagnostic platforms.
- Digital pathology integration and companion diagnostic development will shape the US market through 2030.
Immunohistochemistry Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | KITS (Offering) |
| Forecast Period | 2025-2030 |
| Growth Rate | CAGR of 7.6% from 2025 to 2030 |
| Largest Segment | DIAGNOSTIC APPLICATIONS (Application) |
| Market Size Base Year (Billions) | ~USD 3.56 (2025) |
| Revenue Forecast (Billions) | ~USD 5.14 (2030) |
| Segments Covered | Offering, Type, Clonality, Regulatory Class, Application, End User |
US Immunohistochemistry Market Report Segmentation
6 segment dimensions are covered across the global market.
By Offering
- Antibodies
- Instrument & Software
- Instruments & Software
- Kits
- Reagents
- Services
By Type
- Animal Immunohistochemistry Kits
- Autoimmune Diseases
- Blocking Sera & Reagents
- Cancer
- Chromogenic Substrates
- Diluents
- Drug Development & Testing
- Fixation Reagents
- Human Immunohistochemistry Kits
- Ihc Stainers
- Image Analysis Instruments
- Infectious Diseases
- Microtomes
- Nephrological Diseases
- Neurological Diseases
- Organic Solvents
- Other Diagnostic Applications
- Other Diseases
- Other Reagents
- Other Research Applications
- Other Sample Preparation Instruments
- Primary Antibodies
- Proteolytic Enzymes
- Sample Preparation Instruments
- Secondary Antibodies
- Tissue Processors
By Clonality
- Monoclonal Antibodies
- Polyclonal Antibodies
By Regulatory Class
- Class I/Ii Assay Antibodies
- Class Iii Antibodies
- Class Iii Assay Antibodies
By Application
- Diagnostic Applications
- Forensic Applications
- Research Applications
By End User
- Academic Institutions
- Academic Institutions And Contract Research Organizations
- Hospitals & Diagnostic Laboratories
- Other End Users
- Pharmaceutical & Biopharmaceutical Companies
Target Audience
- Diagnostic Equipment Manufacturers : US-based and international IHC platform manufacturers need market data to assess demand trends, identify expansion opportunities, and benchmark against competitors in the growing American diagnostic equipment sector.
- Pharmaceutical & Biotech Companies : Drug developers require US market insights to understand companion diagnostic requirements, reimbursement landscapes, and adoption rates for IHC-based patient stratification in oncology and precision medicine programs.
- Clinical Laboratory Networks : Large US laboratory operators and pathology groups need market intelligence to optimize service offerings, justify capital investments in automation, and identify emerging diagnostic niches with growth potential.
- Healthcare Investors & Consultants : Investment firms and management consultants require comprehensive US market data to evaluate acquisition targets, assess portfolio companies, and identify emerging opportunities in the diagnostic pathology sector.
- Hospital & Health System Administrators : US hospital procurement and laboratory leadership need market benchmarking data to make informed decisions on IHC technology adoption, vendor selection, and budget allocation for pathology department upgrades.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise US market valuation ($617.9M in 2025) and verified 7.8% CAGR projections through 2030 to support strategic planning, investment decisions, and competitive positioning in the American immunohistochemistry sector.
- US-Specific Regulatory & Reimbursement Insights : Access detailed analysis of FDA approval pathways, Medicare/Medicaid reimbursement trends, and US healthcare policy impacts on IHC adoption, enabling compliant market entry and revenue optimization strategies.
- Competitive Landscape Intelligence : Identify leading US diagnostic companies, laboratory networks, and technology providers dominating the market, along with their market share, product portfolios, and strategic initiatives specific to American healthcare systems.
- End-User Demand Segmentation : Understand purchasing patterns and requirements across US academic medical centers, community hospitals, reference laboratories, and specialty diagnostic centers to tailor solutions and sales strategies effectively.
- Growth Opportunity Mapping : Discover high-potential segments including companion diagnostics, digital pathology integration, and emerging biomarkers in the US market, with actionable recommendations for market expansion and product development.
Frequently asked questions
What is the current size of the US immunohistochemistry market?
The US immunohistochemistry market is valued at $617.9 million in 2025.
What is the projected size of the US immunohistochemistry market by 2030?
The US immunohistochemistry market is projected to reach $899.7 million by 2030.
What is the growth rate of the US immunohistochemistry market?
The US immunohistochemistry market is expected to grow at a compound annual growth rate of 7.8% from 2025 to 2030.
What factors are driving growth in the US immunohistochemistry market?
Key drivers include rising cancer incidence, increased demand for personalized medicine, regulatory support for companion diagnostics, and adoption of automated staining and digital pathology technologies.
Which segments dominate the US immunohistochemistry market?
Oncology applications, particularly cancer diagnosis and biomarker identification, represent the largest segment in the US immunohistochemistry market.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global immunohistochemistry market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Organisation for Economic Co-operation and Development (OECD), National Institutes of Health (NIH), Food and Drug Administration (FDA), ClinicalTrials.gov, Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the total size of the immunohistochemistry market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Immunohistochemistry (IHC) is a laboratory technique that uses antibodies to test, detect, and visualize specific proteins or antigens within tissue sections, utilizing a combination of immunological, anatomical, and biochemical techniques. This method involves binding antibodies conjugating to a detectable marker, such as an enzyme or fluorescent dye, to the target tissues. These antibodies bind to their target antigens, allowing for the localization and quantification of the proteins within the tissue. There are multiple approaches used in immunohistochemistry for drug testing and the diagnosis of chronic diseases, such as cancer, infectious diseases, cardiovascular diseases, diabetes, and autoimmune diseases.
The study provides an in-depth analysis of the immunohistochemistry market based on contemporary market trends and developments, and its potential growth from 2025 to 2030. It includes detailed market trends, the competitive landscape, market size, forecasts, and the analysis of the key Immunohistochemistry product providers.
Stakeholders
- Manufacturers and Distributors of Immunohistochemistry Products
- Third-party Suppliers of Immunohistochemistry Products
- Contract Research Organizations
- Market Research and Consulting Firms
- R&D Centers and Institutes
- Hospitals and Clinics
- Academic Institutions
- Diagnostic Laboratories
Report Objectives
- To define, describe, and forecast the immunohistochemistry market based on offerings, applications, end users, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall immunohistochemistry market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players in the immunohistochemistry market and comprehensively analyze their core competencies and market rankings
- To track and analyze competitive developments such as product launches, acquisitions, expansions, agreements, partnerships, and collaborations in the immunohistochemistry market
- To benchmark players within the immunohistochemistry market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and product strategy
Get the Full Immunohistochemistry Market Report
Full forecast, segment splits, and company analysis for all Immunohistochemistry Market.
- Canada Immunohistochemistry Market
- Germany Immunohistochemistry Market
- UK Immunohistochemistry Market
- France Immunohistochemistry Market
- Italy Immunohistochemistry Market
- Spain Immunohistochemistry Market
- China Immunohistochemistry Market
- Japan Immunohistochemistry Market
- India Immunohistochemistry Market
- Australia Immunohistochemistry Market
- South Korea Immunohistochemistry Market
- Brazil Immunohistochemistry Market
- Mexico Immunohistochemistry Market
- UAE Immunohistochemistry Market
- Rest Of Europe Immunohistochemistry Market
- Rest Of Asia Pacific Immunohistochemistry Market
- Rest Of Latin America Immunohistochemistry Market
- Kingdom Of Saudi Arabia Immunohistochemistry Market
- Rest Of GCC Countries Immunohistochemistry Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report